Neoadjuvant Chemotherapy Treatment Modifications in Ovarian Carcinoma
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference14 articles.
1. Ovarian cancer;Hennessy;Lancet,2009
2. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline;Wright;Gynecol Oncol,2016
3. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study;Ozols;J Clin Oncol,2003
4. Chemotherapy-induced neuropathies—a growing problem for patients and health care providers;Banach;Brain Behav,2017
5. Impact of hematopoietic growth factors on blood transfusion needs, incidence of neutropenia, and overall survival among elderly advanced ovarian cancer patients treated with chemotherapy;Poonawalla;Int J Gynecol Cancer,2016
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The predictive value of NLR, PLR and MLR in the differential diagnosis of benign uterine diseases and endometrial malignant tumors;Discover Oncology;2024-03-31
2. Ovarian cancer in the older patient: where are we now? What to do next?;Therapeutic Advances in Medical Oncology;2023-01
3. Incidence and predictors for chemotherapy modifications and their impact on the outcome of ovarian cancer patients;Archives of Gynecology and Obstetrics;2022-11-03
4. Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics;Cancers;2018-07-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3